IL-1 protects from fatal systemic candidiasis in mice by inhibiting oxidative phosphorylation and hypoxia

Sofia Horn1, Mareike Schmid1, Ivan Berest1

  • 1Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.

Nature Communications
|March 18, 2025
PubMed

Insights

Interleukin-1 receptor (IL-1R) signaling in non-hematopoietic cells is vital for controlling invasive Candida albicans infections. This pathway prevents excessive metabolic activity and hypoxia, crucial for survival against candidiasis.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cell Biology

Background:

  • Invasive Candida albicans infections are life-threatening, with high mortality rates.
  • The role of Interleukin-1 (IL-1) in combating C. albicans is known, but its precise mechanisms are not fully understood.

Purpose of the Study:

  • To elucidate the cellular mechanisms by which IL-1R signaling mediates protection against invasive candidiasis.
  • To investigate the specific cell types and tissues where IL-1R signaling is critical for host defense.

Main Methods:

  • Utilized global and conditional Il1r1 knockout mouse models.
  • Employed single-nucleus RNA sequencing (snRNA-seq) to analyze cellular responses.
  • Assessed fungal clearance, immune cell recruitment, and metabolic changes in infected tissues (kidney and brain).

Main Results:

  • IL-1R signaling in non-hematopoietic cells, particularly in the kidney endothelium, is essential for fungal clearance, independent of neutrophil recruitment.
  • In the brain, IL-1R signaling indirectly recruits immune cells by modulating chemokines and adhesion molecules.
  • Il1r1 deficiency leads to rapid metabolic reprogramming, characterized by excessive oxidative phosphorylation and localized hypoxia in kidney tissues, which promotes fungal growth and pathogenicity.

Conclusions:

  • IL-1R signaling in non-hematopoietic cells is indispensable for preventing fatal invasive candidiasis.
  • This signaling pathway acts by suppressing detrimental metabolic shifts, including excessive oxidative phosphorylation and hypoxia, at infection sites.